newsfilter
← Latest News
GlobeNewswire·

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-19

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary of TLC (NASDAQ:TLC, TWO: 4152))) that specializes in the development of proprietary inhalable liposome formulation programs, recently presente